Cite
HARVARD Citation
Pham, C. et al. (2022). Re: Lin I, Melsheimer R, Bhak RH, et al. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin. 2022;38(4):613–627. Current medical research and opinion. pp. 2241-2242. [Online].